Jeff Kim is the co-founder and CEO of Slingshot Biosciences, a biotech that designs and manufactures synthetic cells for R&D, clinical diagnostics, and engineered cell therapies. Slingshot Biosciences' mission is to overcome supply chain and cost barriers that restrict access to advanced diagnostics and therapeutics.
Jeff is a serial entrepreneur, having co-founded and run multiple successful companies, including Radiant Genomics, which was eventually acquired by Zymergen, and Pattern Ag, a company mapping soil microbes to help farmers grow their bottom line. Before Radiant, Jeff was a scientist at the Lawrence Berkeley National Lab, and was the project lead for jet fuel development at Amyris Biotechnologies.
Get the latest insights from The Biotech Startups Podcast delivered straight to your inbox.
Subscribe to our twice-weekly newsletter for updates, news, and more—everything you need to stay ahead in biotech.